CERN:NGS-Cerner Corporation

EQUITY | Health Information Services | Nasdaq Global Select

Last Closing

USD 75.83

Change

-0.29 (-0.38)%

Market Cap

USD 17.00B

Volume

1.28M

Analyst Target

USD 69.94
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cerner Corp is a supplier of health care information technology, and offers software, professional services, medical device integration, remote hosting and employer health and wellness services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

-12.70 (-14.28%)

USD 40.37B
HQY HealthEquity Inc

-1.39 (-1.73%)

USD 6.92B
RCM R1 RCM Inc

-0.06 (-0.49%)

USD 5.04B
TXG 10X Genomics Inc

+0.88 (+3.10%)

USD 4.47B
PGNY Progyny Inc

-0.48 (-1.48%)

USD 3.68B
CERT Certara Inc

+0.03 (+0.18%)

USD 2.83B
GDRX Goodrx Holdings Inc

-0.05 (-0.70%)

USD 2.70B
PINC Premier Inc

-0.28 (-1.32%)

USD 2.51B
PRVA Privia Health Group Inc

-0.25 (-1.34%)

USD 2.15B
BTSG BrightSpring Health Services I..

-0.22 (-2.02%)

USD 1.81B

ETFs Containing CERN

MIDF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 44.60% 74% C 85% B
Dividend Return 0.34% 25% F 6% D-
Total Return 44.95% 74% C 85% B
Trailing 12 Months  
Capital Gain 23.36% 61% D- 87% B+
Dividend Return 0.29% 25% F 3% F
Total Return 23.65% 61% D- 86% B+
Trailing 5 Years  
Capital Gain 43.35% 55% F 64% D
Dividend Return 0.34% 25% F 1% F
Total Return 43.69% 55% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 0.27% 31% F 43% F
Dividend Return 0.27% 30% F 35% F
Total Return 0.00% 2% F N/A F
Risk Return Profile  
Volatility (Standard Deviation) 17.44% 82% B 69% C-
Risk Adjusted Return 1.56% 29% F 34% F
Market Capitalization 17.00B 100% F 97% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.90 80% 26%
Price/Book Ratio 4.81 45% 24%
Price / Cash Flow Ratio 0.00 9% 12%
Price/Free Cash Flow Ratio 0.00 9% 4%
Management Effectiveness  
Return on Equity 12.69% 89% 79%
Return on Invested Capital N/A N/A N/A
Return on Assets 7.21% 84% 89%
Debt to Equity Ratio 8.90% 63% 78%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector